Zoetis receives conditional approval for Dectomax-CA1 injectable

Zoetis (ZTS) “announced that Dectomax-CA1 Injectable is the first and only parasite control product to receive conditional approval from the U.S. Food and Drug Administration for the prevention and treatment of infestations caused by the larvae of Cochliomyia hominivorax, and prevention of reinfestation for 21 days. This conditional approval applies to beef cattle, female dairy cattle less than 20 months of age, pregnant beef cows, newborn calves and bulls. Zoetis is committed to supporting livestock producers with scientific solutions for this economically devastating pest. New World screwworm poses a continuing threat to livestock health, and the financial impacts of the disease to the U.S. agricultural economy are estimated in the billions of dollars.”